Outline:
Introduction to allopathic drug management strategies in treating Alzheimer’s & Dementia in Canada.
Introduce current treatment goals, physiologic targets, and guiding principles for the clinical drug selection in dementia and Alzheimer’s disease treatment.
10 min
Comparing the 2 major drug classes involved in current established drug management options for Dementia & Alzheimer’s Disease and the four drugs used to treat Dementia & Alzheimer’s Disease in Canada:
(i) Cholinesterase Inhibitors:
-
- Donepezil
- Riastigmine
- Galantamine
(ii) N-methy-D-aspartate receptor antagonist (NMDA): 35 min
-
- Memantine
45 min
Drug discussion will include (with supportive clinical studies), discussion of mechanisms of action and clinical indications of use, contra-indications of use, side effects of drug use and herb/nutrient interactions.
45 min
Brief look at evolving treatment research and new strategies being investigated including up and coming biologics (disease-modifiers/immunotherapy):
-
- Aducanumab
- Gantenerumab
- Donanemab
- Lecanemab
15 min
Conclusion / Summary
5 min
Total: 2 hrs
As presented at our Live 2023 ND Conference: Naturopathic Approaches to Various Disorders. A complete list of webinars from the 2023 Conference can be found here.
Presented by Dr Carol Laic ND MEd